ClinicalTrials.Veeva

Menu

HILO-HF Registry: High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure

U

University of Alberta

Status

Completed

Conditions

Acute Heart Failure

Study type

Observational

Funder types

Other

Identifiers

NCT03110042
HILO-HF Registry

Details and patient eligibility

About

The HILO-HF Registry is a single centre registry that will be performed to provide information on the usual baseline oxygen saturation (SpO2) in patients presenting to ED with a primary ED diagnosis of AHF

Enrollment

60 patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients >40 years of age presenting to the ED with AHF
  • With or without tested BNP
  • With or without admission to hospital for treatment of HF\
  • Patients must be recruited within the first 24 hours of presenting to the ED.

Exclusion criteria

  • Patients on home oxygen
  • Patients with known prior hypercapnic failure (PaCO2>50 mmHg)
  • Asthma
  • Primary pulmonary hypertension
  • Patients requiring urgent positive pressure ventilation or intubation or on >10 L/min oxygen

Trial design

60 participants in 1 patient group

Observational Cohort
Description:
All patients will receive usual standard of care with the heart failure management including the routine supplemental oxygen therapy.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems